Collegium Pharmaceutical, Inc. (COLL)
24.61
-0.74
(-2.92%)
USD |
NASDAQ |
Aug 31, 16:00
24.64
+0.03
(+0.12%)
After-Hours: 20:00
Collegium Pharmaceutical Cash from Operations (Annual) : 329.32M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 329.32M |
| December 31, 2024 | 204.98M |
| December 31, 2023 | 274.75M |
| December 31, 2022 | 124.23M |
| December 31, 2021 | 103.56M |
| December 31, 2020 | 93.94M |
| December 31, 2019 | 27.78M |
| Date | Value |
|---|---|
| December 31, 2018 | 169.39M |
| December 31, 2017 | -67.02M |
| December 31, 2016 | -75.05M |
| December 31, 2015 | -21.57M |
| December 31, 2014 | -17.95M |
| December 31, 2013 | -16.53M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Innoviva, Inc. | 196.93M |
| Zevra Therapeutics, Inc. | -1.598M |
| Supernus Pharmaceuticals, Inc. | 47.33M |
| Indivior Pharmaceuticals, Inc. | -27.00M |
| Crinetics Pharmaceuticals, Inc. | -377.92M |